These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10838527

  • 1. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
    Cantero R, Torres AJ, Maestro ML, Hernando F, Sanz MT, Del Barco V, Gómez A, Fernández C, Balibrea JL.
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1119-25. PubMed ID: 10838527
    [Abstract] [Full Text] [Related]

  • 2. Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer.
    Cantero R, Torres AJ, Maestro M, Fernández C, Hernando F, del Barco V, Sanz T, Balibrea JL.
    World J Surg; 1999 Dec; 23(12):1294-9; discussion 1299-300. PubMed ID: 10552124
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
    Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D, Hung MC.
    Mol Carcinog; 1992 Dec; 5(3):213-8. PubMed ID: 1350198
    [Abstract] [Full Text] [Related]

  • 4. Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue.
    Diez M, Pollán M, Maestro M, Torres A, Ortega D, Gómez A, Sánchez A, Hernando F, Balibrea JL.
    Br J Cancer; 1997 Dec; 75(5):684-9. PubMed ID: 9043025
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM, Levitzki A, Wu LH, Chang KT, Cheng CC, Gazit A, Perng RP.
    Cancer Res; 1996 Mar 01; 56(5):1068-74. PubMed ID: 8640763
    [Abstract] [Full Text] [Related]

  • 6. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
    Akita K, Inagaki H, Sato S, Niimi T, Maeda H, Ninomiya S, Achiwa H, Kawaguchi H, Yamakawa Y, Fujii Y, Shimizu S, Eimoto T, Ueda R.
    Jpn J Cancer Res; 2002 Sep 01; 93(9):1007-11. PubMed ID: 12359054
    [Abstract] [Full Text] [Related]

  • 7. [Study of the expression of proliferating cell nuclear antigen and p185 in non-small cell lung carcinoma].
    Alemany Monraval P, Martorell Cebollada M, Salvador Villalba I, Martínez Leandro E.
    Arch Bronconeumol; 1996 Apr 01; 32(4):165-9. PubMed ID: 8689012
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF.
    Hum Pathol; 2002 Jan 01; 33(1):105-10. PubMed ID: 11823980
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
    Nemunaitis J, Klemow S, Tong A, Courtney A, Johnston W, Mack M, Taylor W, Solano M, Stone M, Mallams J, Mues G.
    Am J Clin Oncol; 1998 Apr 01; 21(2):155-60. PubMed ID: 9537203
    [Abstract] [Full Text] [Related]

  • 10. HER-2/neu oncogene and estrogen receptor expression in non small cell lung cancer patients.
    Alerić I, Razumović JJ, Koprivica B.
    Med Pregl; 2012 Apr 01; 65(5-6):210-5. PubMed ID: 22730705
    [Abstract] [Full Text] [Related]

  • 11. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y, Zhang XR, Fu J, Tan W, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):369-72. PubMed ID: 15312350
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of the quantitative measurement of the oncoprotein p185(Her-2/neu) in a group of patients with breast cancer and positive node involvement.
    Bohn U, Aguiar J, Bilbao C, Murias A, Vega V, Chirino R, Díaz-Chico N, Díaz-Chico JC.
    Int J Cancer; 2002 Oct 20; 101(6):539-44. PubMed ID: 12237894
    [Abstract] [Full Text] [Related]

  • 13. Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin.
    Nguyen DM, Chen A, Mixon A, Schrump DS.
    J Thorac Cardiovasc Surg; 1999 Nov 20; 118(5):908-15. PubMed ID: 10534697
    [Abstract] [Full Text] [Related]

  • 14. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 15. HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival.
    Selvaggi G, Scagliotti GV, Torri V, Novello S, Leonardo E, Cappia S, Mossetti C, Ardissone F, Lausi P, Borasio P.
    Cancer; 2002 May 15; 94(10):2669-74. PubMed ID: 12173335
    [Abstract] [Full Text] [Related]

  • 16. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
    Schneider PM, Praeuer HW, Stoeltzing O, Boehm J, Manning J, Metzger R, Fink U, Wegerer S, Hoelscher AH, Roth JA.
    Br J Cancer; 2000 Aug 15; 83(4):473-9. PubMed ID: 10945494
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of the p185 protein in colorectal cancer.
    Sanz-Casla MT, Vidaurreta M, Maestro ML, López JA, Jiménez F, Fernández C, Maestro C, Balibrea JL, Cerdán FJ.
    Rev Esp Enferm Dig; 2004 Feb 15; 96(2):102-9. PubMed ID: 15255019
    [Abstract] [Full Text] [Related]

  • 18. [P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years].
    Moreno Sierra J, Maestro de las Casas ML, Redondo González E, Fernández Pérez C, del Barco Barriuso V, Sanz Casla MT, Blanco Jiménez E, Silmi Moyano A, Resel Estévez L.
    Arch Esp Urol; 2000 Apr 15; 53(3):238-44. PubMed ID: 10851729
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.
    Müller V, Thomssen C, Karakas C, Eustermann I, Ramirez Porras J, Coith C, Berger J, Löning T, Jänicke F, Pantel K.
    Int J Biol Markers; 2003 Apr 15; 18(1):13-20. PubMed ID: 12699058
    [Abstract] [Full Text] [Related]

  • 20. p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
    Nanni P, Pupa SM, Nicoletti G, De Giovanni C, Landuzzi L, Rossi I, Astolfi A, Ricci C, De Vecchi R, Invernizzi AM, Di Carlo E, Musiani P, Forni G, Menard S, Lollini PL.
    Int J Cancer; 2000 Jul 15; 87(2):186-94. PubMed ID: 10861472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.